Mereo BioPharma Group plc (MPH.L) (MPH) News Today → This is the best new way to score with AI (From Weiss Ratings) (Ad) Free MPH Stock Alerts GBX 26.50 -0.50 (-1.85%) (As of 12/17/2020) Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative April 14, 2024 | morningstar.comMereo BioPharma Group PLC ADR MREOFebruary 24, 2024 | msn.comMereo BioPharma Group plc - Depositary Receipt () (MREO) Price Target Increased by 17.65% to 5.10February 23, 2024 | benzinga.comMereo BioPharma Group Stock (NASDAQ:MREO), Insider Trading ActivityFebruary 22, 2024 | wsj.comMereo BioPharma Group PLC ADRJanuary 8, 2024 | msn.comMereo BioPharma provides update on pipeline progress, reaffirms cash runway guidanceJanuary 8, 2024 | markets.businessinsider.comBTIG Keeps Their Buy Rating on Mereo Biopharma Group Plc (MREO)January 8, 2024 | markets.businessinsider.comMereo BioPharma Provides Update on Pipeline Progress and Corporate DevelopmentsDecember 13, 2023 | seekingalpha.comMereo BioPharma: Lagging Stock Despite Positive DataOctober 23, 2023 | markets.businessinsider.comMereo BioPharma Reports on Recent Program Developments and Provides Financial UpdateJune 14, 2023 | markets.businessinsider.comSVB Securities Sticks to Its Buy Rating for Mereo Biopharma Group Plc (MREO)June 6, 2023 | msn.comUltragenyx, Mereo shares gain after positive results from study of bone disorder treatmentJune 6, 2023 | msn.comUltragenyx, Mereo gain on Phase 2 data for bone disorder therapyMay 31, 2023 | technews.tmcnet.comMereo BioPharma to Present at the Jefferies Healthcare ConferenceMay 29, 2023 | msn.comNavigating Mereo BioPharma's Future: Risky Proposition Despite Strides In Rare Disease TreatmentMay 5, 2023 | msn.comMereo BioPharma transfers ADS listing from Nasdaq Global Market to Nasdaq Capital MarketMay 5, 2023 | technews.tmcnet.comMereo BioPharma Announces Listing Transfer to Nasdaq Capital MarketMarch 28, 2023 | benzinga.comMereo BioPharma Reports Full Year 2022 Financial Results and Recent HighlightsMarch 21, 2023 | msn.comMereo soars ~25% after FDA, EMA guidance on main goals of trial for lung disease drugDecember 21, 2022 | benzinga.comShort Volatility Alert: Mereo BiopharmaOctober 28, 2022 | technews.tmcnet.comMereo BioPharma Reaches Cooperation Agreement with Rubric Capital ManagementOctober 17, 2022 | marketwatch.comMereo BioPharma Gets FDA Fast-Track Designation for Alvelestat >MREOOctober 17, 2022 | markets.businessinsider.comMereo BioPharma: FDA Grants Fast Track Designation For Alvelestat - Quick FactsOctober 5, 2022 | marketwatch.comRubric Capital Management Increases Slate of Proposed Mereo BioPharmaDirector Nominees to FiveSeptember 26, 2022 | benzinga.comMereo BioPharma Offered to Settle Proxy Contest with Rubric Capital Management by Putting Rubric Principal and Second New Director on the BoardSeptember 22, 2022 | seekingalpha.comMereo BioPharma: An Activist Pressure With A Potentially Significant UpsideSeptember 13, 2022 | yahoo.comTitus Welliver Joins Titans Season 4 as Lex Luthor, November Premiere SetAugust 23, 2022 | seekingalpha.comMereo cites 'deficiencies' in investor Rubric's letter seeking general meeting, removal of directorsJuly 5, 2022 | finance.yahoo.comMereo BioPharma Regains Compliance with Nasdaq Minimum Bid Price RequirementJune 17, 2022 | finance.yahoo.comWhy Mereo BioPharma Shares Are Jumping TodayJune 17, 2022 | seekingalpha.comMereo BioPharma: Activist Pressure In A Net-Net BiopharmaMay 17, 2022 | markets.businessinsider.comAlliance Pharma To Acquire LGC's Bio-analytical Business Arm For Undisclosed SumMay 11, 2022 | finance.yahoo.comARTRYA SIGNS FIRST U.S. HOSPITAL CLINICAL PARTNERSHIP WITH HUNTSVILLE HEART CENTERMay 11, 2022 | finance.yahoo.comNew Research Continues to Reinforce Effectiveness of Massage Therapy for Relief of Chronic PainMay 7, 2022 | tmcnet.comMereo BioPharma to Host Conferene Call Highlighting Top-line Clinical Data from "ASTRAEUS" Phase 2 Study of Alvelestat Get Mereo BioPharma Group plc (MPH.L) News Delivered to You Automatically Sign up to receive the latest news and ratings for MPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Wall Street legend who predicted 2021 tech crash issues new warning (Ad)People around the world follow 50-year Wall Street veteran Marc Chaikin for his surprisingly accurate stock predictions. And he just issued an urgent WARNING for some of the most popular stocks in U.S. history. Watch his stock warning right here, 100% free of charge MPH Media Mentions By Week MPH Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MPH News Sentiment▼0.000.54▲Average Medical News Sentiment MPH News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MPH Articles This Week▼00▲MPH Articles Average Week Get Mereo BioPharma Group plc (MPH.L) News Delivered to You Automatically Sign up to receive the latest news and ratings for MPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SCLP News POLB News FARN News REDX News FUM News ETX News AREC News C4XD News SAR News AVCT News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:MPH) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersBiden to Drop BOMBSHELL June 13th?Paradigm PressAmazon's betting big on this unknown AI companyManward PressWall Street legend who predicted 2021 tech crash issues new warningChaikin AnalyticsThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportTop 5 AI Stocks to Buy for 2024Market Moving TrendsTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop 5 Tech Stocks to Buy for 2024Daily Market Alerts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mereo BioPharma Group plc (MPH.L) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
